About Quanterix

Quanterix develops ultra-sensitive biomarker detection technology for healthcare and research. The company's platforms enable precision measurement of proteins in blood, cerebrospinal fluid, and tissue at unprecedented sensitivity levels, supporting neurology, oncology, immunology, and other disease areas where early detection and monitoring matter. Through dual modality analysis combining liquid and spatial proteomics, Quanterix delivers validated biomarker insights used in clinical trials, diagnostics development, and precision medicine. The technology supports pharmaceutical companies, research institutions, and diagnostic laboratories worldwide in advancing from discovery to clinical application.